Latest Breaking News On - Elia aguado fraile - Page 1 : comparemela.com

Repare Therapeutics Inc. , a leading clinical-stage precision oncology company, today announced it will present initial data from Module 1 and 2 of its ongoing Phase 1 MYTHIC clinical trial in a.

United statesMemorial sloan kettering cancer centerNew yorkDavid galloMichael zimmermanEzra rosenTimothya yapElia aguado fraileInternational conference on molecularUniversity of texas md anderson cancer centerCompany nasdaqRepare therapeutics incRepare therapeuticsMolecular targetsCancer therapeuticsCancer center